IM Cannabis (NASDAQ:IMCC) Stock, Quote.Headers.trade-ideas

IM Cannabis

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

elsa-olofsson-12-Zs1xIEtA-unsplash(28)

Cannabis

Earnings

News

CSE:IMCC

IMCC

The company, announced  its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023. The company also reported a 129% year-over-year increase in IMC Germany sales to CA$3.5 million, making up 24% of the entire company revenue. 

IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY

pexels-pixabay-128867

ETRGF

TSX:OGI

TSXV:ENTG

YCBD

Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30, 2024, on Wednesday, Aug. 14, 2024. cbdMD, Inc. (NYSE: YCBD) said it will host a conference call at 4:20 pm Eastern Time, on Wednesday, Aug. 14, 2024, to discuss the company&#39;s June 30, 2024 third quarter of fiscal 2024 financial results and business progress. Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) its second quarter 2024 financial results will be released after market close on Monday, Aug. 26, 2024.  The company will host a conference call to discuss the results and provide an operational update and recap of achievements on Tuesday, Aug. 27, 2024. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, Aug. 13, 2024, before market open. The company will host a conference call to discuss its results with details the same day at 8:00 am Eastern Time.

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

AI Generated Image 

Government

Regulations

Small Cap

IPOs

Markets

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

INCR

TCNNF

Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling of cannabis to Schedule III of the Controlled Substances Act and Germany’s recent decriminalization have ignited optimism within the sector.

European Cannabis Companies Race To The Nasdaq: $1B In Tax Break On The Horizon

IM Cannabis Corp

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a leader in the medical cannabis industry, has announced it is back in compl...

IM Cannabis Corp. Regains NASDAQ Compliance

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp (IMC) reported a number of significant developments in July 2024, including a ...

IM Cannabis Corp Optimizes Operations and Maintains NASDAQ Compliance

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a prominent player in the medical cannabis industry with operations in Israe...

IM Cannabis Corp. Unveils Q2 2024 Financials

Roth MKM analyst Scott Fortune assigned a Buy rating to IM Cannabis Corp (IMCC – Research Report) today and set a price target of $6.00. The compan...

IM Cannabis Corp (IMCC) Receives a Buy from Roth MKM

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp. has reported an impressive 200% sales increase in its German sector following...

IM Cannabis Corp. Sees Soaring Sales in Germany

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>IM Cannabis</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/imcc-stock-quote/"><strong>IMCC</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>IM Cannabis reported earnings per share of -17 cents. This was above the analyst estimate for EPS of -85 cents.</li><li>The company reported revenue of $10.78 million.</li><li>This was 12.66% better than the analyst estimate for revenue of $9.57 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/imcc-stock-earnings-im-cannabis-for-q2-of-2024/">IMCC Stock Earnings: IM Cannabis Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

IMCC Stock Earnings: IM Cannabis Beats EPS, Beats Revenue for Q2 2024

IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript

IM Cannabis reports Q2 results

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a player in the cannabis market, is refocusing its efforts by exiting the Ca...

IM Cannabis Corp: Strategic Refocus Amidst Challenges

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a leader in the medical cannabis sector, has enhanced its board of directors...

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

IM Cannabis

IM Cannabis (IMCC) Forecast

IM Cannabis (NASDAQ:IMCC) Stock, Quote.Headers.trade-ideas